Glenmede Trust’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-337
Closed -$13K 2391
2020
Q3
$13K Sell
337
-24
-7% -$1.2K ﹤0.01% 1794
2020
Q2
$19K Buy
361
+201
+126% +$11.5K ﹤0.01% 1618
2020
Q1
$7K Hold
160
﹤0.01% 2585
2019
Q4
$7K Buy
160
+64
+67% +$3K ﹤0.01% 2585
2019
Q3
$5 Buy
96
+52
+118% +$2.98K ﹤0.01% 2662
2019
Q2
$2 Hold
44
﹤0.01% 2892
2019
Q1
$2 Sell
44
-13
-23% -$775 ﹤0.01% 2868
2018
Q4
$3 Buy
+57
New +$4.04K ﹤0.01% 2712
2017
Q1
Sell
-500
Closed -$7K 2770
2016
Q4
$7K Hold
500
﹤0.01% 2182
2016
Q3
$7K Buy
+500
New +$7.3K ﹤0.01% 2203

Other funds holding TRHC

Glenmede Trust's TRHC Position: Q4 2020 in Review

Glenmede Trust sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q4 2020, closing a stake of 337 shares — an estimated $13K sold.

Glenmede Trust first reported a position in TRHC in Q3 2016 and held it in 10 quarters. The position peaked at $19K in Q2 2020. 163 funds tracked by Wall St. Rank hold TRHC as of Q4 2020.

  • Glenmede Trust reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Glenmede Trust sold 337 Tabula Rasa HealthCare, Inc. Common Stock shares in Q4 2020, an estimated $13K.
  • Glenmede Trust first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q3 2016 and held it in 10 quarters.
  • Glenmede Trust's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $19K in Q2 2020.
  • 163 funds tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.